Positions

Overview

  • Infectious diseases doctor
    Internist
    Pediatrician
    Global health researcher based in Africa
    HIV and viral hepatitis expert
    Mentor and trainer of trainers in public health, clinical medicine, and clinical research

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Hepatosplenic schistosomiasis in Zambian adults is characterized by increased liver stiffness: A nested case-control study.  Heliyon.  6. 2020
    2020 Characterizing the double-sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa.  Journal of the International AIDS Society.  23. 2020
    2020 Effect of Enhanced Adherence Package on Early ART Uptake Among HIV-Positive Pregnant Women in Zambia: An Individual Randomized Controlled Trial.  AIDS and Behavior.  2020
    2020 Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia.  PLoS ONE.  15. 2020
    2020 Propranolol reduces portal vein diameter in schistosomal liver disease with portal hypertension: A prospective cohort study.  American Journal of Tropical Medicine and Hygiene.  102:832-837. 2020
    2019 Concordance of Self- and Partner-Reported Alcohol Consumption Among Couples Experiencing Intimate Partner Violence in Zambia.  Alcoholism: Clinical and Experimental Research.  43:2568-2577. 2019
    2019 High Rates of Hepatitis B Virus (HBV) Functional Cure among Human Immunodeficiency Virus-HBV Coinfected Patients on Antiretroviral Therapy in Zambia 2019
    2019 Care Continuum and Postdischarge Outcomes among HIV-Infected Adults Admitted to the Hospital in Zambia.  Open Forum Infectious Diseases.  6. 2019
    2019 Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.  Clinical Infectious Diseases.  69:1345-1352. 2019
    2019 Changes in rapid hiv treatment initiation after national “treat all” policy adoption in 6 sub-saharan african countries: Regression discontinuity analysis.  PLoS Medicine.  16. 2019
    2019 Temporal trends in co-trimoxazole use among children on antiretroviral therapy and the impact of co-trimoxazole on mortality rates in children without severe immunodeficiency.  Journal of the Pediatric Infectious Diseases Society.  8:450-460. 2019
    2019 Hepatitis B Therapy as HIV Prevention in Africa: A Case Series From Zambia.  Hepatology.  69:458-460. 2019
    2018 High prevalence of binge drinking among people living with HIV in four African countries.  Journal of the International AIDS Society.  21. 2018
    2018 Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration.  Journal of the International AIDS Society.  21. 2018
    2018 Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.  Journal of the International AIDS Society.  21. 2018
    2018 Mental health comorbidity in low-income and middle-income countries: a call for improved measurement and treatment.  Lancet Psychiatry.  5:864-866. 2018
    2018 Lamivudine monotherapy as a holding regimen for HIV-positive children.  PLoS ONE.  13. 2018
    2018 No Impact of Hepatitis B Virus Infection on Early Mortality among Human Immunodeficiency Virus-Infected Patients in Southern Africa.  Clinical Infectious Diseases.  67:1310-1311. 2018
    2018 HIV Self-Testing in Lusaka Province, Zambia: Acceptability, Comprehension of Testing Instructions, and Individual Preferences for Self-Test Kit Distribution in a Population-Based Sample of Adolescents and Adults.  AIDS Research and Human Retroviruses.  34:254-260. 2018
    2018 Retention and mortality on antiretroviral therapy in sub-Saharan Africa: Collaborative analyses of HIV treatment programmes: Collaborative.  Journal of the International AIDS Society.  21. 2018
    2018 Assessing the association between changing NRTIs when initiating second-line ART and treatment outcomes 2018
    2018 Chronic hepatitis B virus monoinfection at a university hospital in Zambia.  World Journal of Hepatology.  10:622-628. 2018
    2018 Field performance of the Determine HBsAg point-of-care test for diagnosis of hepatitis B virus co-infection among HIV patients in Zambia.  Journal of Clinical Virology.  98:5-7. 2018
    2018 Hepatitis B virus contact disclosure and testing in Lusaka, Zambia: A mixed-methods study.  BMJ Open.  8. 2018
    2018 Point-of-care urine ethyl glucuronide testing to detect alcohol use among HIV-hepatitis B virus coinfected adults in Zambia.  AIDS and Behavior.  22:2334-2339. 2018
    2018 Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose 2018
    2018 Rifaximin reduces markers of inflammation and bacterial 16S rRNA in Zambian adults with hepatosplenic schistosomiasis: A randomized control trial.  American Journal of Tropical Medicine and Hygiene.  98:1152-1158. 2018
    2017 Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.  BMC Infectious Diseases.  17. 2017
    2017 Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkers.  Transactions of The Royal Society of Tropical Medicine and Hygiene.  111:425-432. 2017
    2017 Risk factors for impaired fasting glucose or diabetes among HIV infected patients on ART in the Copperbelt Province of Zambia.  Journal of Diabetes & Metabolic Disorders.  16. 2017
    2017 Impact of Antiretroviral Therapy on Liver Fibrosis among Human Immunodeficiency Virus-Infected Adults with and Without HBV Coinfection in Zambia.  Clinical Infectious Diseases.  64:1343-1349. 2017
    2017 Awareness and management of elevated blood pressure among human immunodeficiency virus–infected adults receiving antiretroviral therapy in urban Zambia: A call to action.  Global Health Action.  10:1-5. 2017
    2016 Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia.  Tropical Medicine and International Health.  21:1435-1441. 2016
    2016 Kaposi sarcoma risk in HIV-infected children and adolescents on combination antiretroviral therapy from sub-Saharan Africa, Europe, and Asia.  Clinical Infectious Diseases.  63:1245-1253. 2016
    2016 Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.  International Journal of Infectious Diseases.  51:97-102. 2016
    2016 Absence of active hepatitis C virus infection in human immunodeficiency virus clinics in Zambia and Mozambique.  Open Forum Infectious Diseases.  3. 2016
    2016 Hepatitis B infection, viral load and resistance in HIV-infected patients in Mozambique and Zambia.  PLoS ONE.  11. 2016
    2016 Corrigendum to "Hepatitis B viral load in dried blood spots: A validation study in Zambia" [J. Clin. Virol. 72 (2015) 20-24] Doi: 10.1016/j.jcv.2015.08.019.  Journal of Clinical Virology.  74:88. 2016
    2015 Pediatric HIV-HBV coinfection in Lusaka, Zambia: Prevalence and short-term treatment outcomes.  Journal of Tropical Pediatrics.  61:464-467. 2015
    2015 Hepatitis B viral load in dried blood spots: A validation study in Zambia.  Journal of Clinical Virology.  72:20-24. 2015
    2015 Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.  Liver International.  35:1886-1892. 2015
    2015 Implementation of routine screening for chronic hepatitis B virus co-infection by HIV clinics in Lusaka, Zambia.  Journal of Viral Hepatitis.  22:858-860. 2015
    2015 Response to 'Is AST-to-platelet ratio index a reliable tool in HIV patients in Africa?'.  Liver International.  35:2060. 2015
    2015 Validation of medicaid claims-based diagnosis of myocardial infarction using an HIV clinical cohort.  Medical Care.  53:e41-e48. 2015
    2014 Chronic hepatitis B virus coinfection is associated with renal impairment among zambian HIV-infected adults.  Clinical Infectious Diseases.  59:1757-1760. 2014
    2014 Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.  Clinical Infectious Diseases.  58:1473-1480. 2014
    2014 Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia.  AIDS Research and Human Retroviruses.  30:949-955. 2014
    2014 Leveraging rapid implementation of an HIV treatment policy to reduce confounding in observational analysis of antiretroviral outcomes.  Tropical Medicine and International Health.  19:499-500. 2014
    2014 Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in Urban Zambia.  AIDS Research and Human Retroviruses.  30:74-77. 2014
    2013 Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the southeastern United States.  AIDS Research and Human Retroviruses.  29:1068-1074. 2013
    2013 Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation 2013
    2013 Do all candidemic patients need an ophthalmic examination?.  International Journal of Infectious Diseases.  17. 2013
    2012 Clinical scoring for risk of resistant organisms in pneumonia: Right idea, wrong interpretation.  Clinical Infectious Diseases.  55:749-750. 2012
    2011 Herpes simplex virus type 2 mimicking necrotizing fasciitis.  Annals of Internal Medicine.  155:567-568. 2011
    2009 Influenza A virus subtyping: Paradigm shift in influenza diagnosis.  Journal of Clinical Microbiology.  47:3055-3056. 2009

    Research Overview

  • My research focuses on 3 areas:

    #1 Hepatitis B virus infection in sub-Saharan Africa: I want to better understanding the natural history of the infection, disease co-factors, diagnostics, and accelerating elimination through scale-up of treatment and discovery of new therapeutics. My research on HBV occurs in sub-Saharan Africa where there are distinct viral genotypes and where integration with the HIV response offers significant opportunities.

    #2 Nexus of Alcohol and HIV: I want to understand how alcohol undermines efforts at HIV epidemic control, develop sustainable and effective alcohol reduction treatment for people living with HIV, and advance the use of alcohol biomarkers, which reduce measurement issues.

    #3 Inpatient and post-discharge HIV care in sub-Saharan Africa: I want to develop individualized and health system interventions to improve HIV care at the point of hospitalization and in the post-discharge period.

    • Principal Investigator On

  • Mechanisms of HBV Functional Cure During Tenofovir-based ART in HIV/HBV Coinfection  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2024
  • Feasibility of an Integrated Intervention to Reduce Advanced HIV Disease Mortality among Hospitalized Adults in Zambia  awarded by National Institute of Mental Health/NIH/DHHS 2019 - 2022
  • Feasibility and Preliminary Efficacy of a Transdiagnostic Cognitive Behavioral Therapy Treatment Approach for Alcohol Misuse Integrated Within HIV Care in Zambia  awarded by Columbia University 2019 - 2021
  • Feasibility and Preliminary Effectiveness of a Transdiagnostic Cognitive Behavioral Therapy Treatment Approach for Alcohol Misuse Integrated Within HIV Care in Zambia  awarded by Johns Hopkins University 2018 - 2021
  • Evaluating Implementation Strategies to Scale-Up Transdiagnostic Evidence-Based Mental Health Care in Zambia  awarded by Centre for Infectious Disease Research in Zambia (CIDRZ) 2018 - 2021
  • Management of HEP Cohort  awarded by UNIVERSITY OF BERN 2018 - 2019
  • Impact of Antiretroviral Therapy on Liver Fibrosis in Zambian HIV/HBV Patients  awarded by Fogarty International Center/NIH/DHHS 2015 - 2019
  • Private Grant  awarded by Gilead Sciences 2016 - 2019
  • UAB Center for AIDS Research - Care Cascade and Discharge Outcomes of Hospitalized HIV + Aambians  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • HVTN 705 Protocol Funds  awarded by Hutchinson (Fred) Cancer Research Center 2017 - 2018

    • Investigator On

    Teaching Overview

  • I serve as a teaching medicine attending at UAB hospital, I mentor global health-oriented students through the UAB Sparkman Center and medical students at UAB medical school. I also serve as a mentor for numerous public health practitioners and junior investigators at Center for Infectious Disease Research in Zambia (www.cidrz.org) and for masters and PhD students at University of Zambia.

    • Education And Training

  • Doctor of Medicine, Loyola University Chicago 2006
  • Bachelor of Science or Mathematics in Biology, University of Illinois System : Urbana-Champaign 2001
  • Rush Medical College of Rush University, Residency 2010
  • University of North Carolina Hospital Medicine, Postdoctoral Fellowship 2014

    • Full Name

  • Michael Vinikoor